CN100344770C - Primer, probe for rat lymph cell P59 fyn gene quantitative expression test - Google Patents
Primer, probe for rat lymph cell P59 fyn gene quantitative expression test Download PDFInfo
- Publication number
- CN100344770C CN100344770C CNB021461333A CN02146133A CN100344770C CN 100344770 C CN100344770 C CN 100344770C CN B021461333 A CNB021461333 A CN B021461333A CN 02146133 A CN02146133 A CN 02146133A CN 100344770 C CN100344770 C CN 100344770C
- Authority
- CN
- China
- Prior art keywords
- primer
- fyn
- probe
- gene
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to a primer and a probe for the quantitative expression and test of a rat lymphocyte P59<fyn> gene, which is characterized in that the sequence of a primer 378U on the upper stream is 5'TCGCGGTGAAGGCTATGT3' in a primer sequence, the sequence of a primer 485L on the downstream is 5'CCAGGTTCTCCCCCTCACTAA3', and the sequence of a probe 423-FT is 5'CTGCAGCACCCTTCCAGCGCAACCC3'. The present invention has the advantages of good sensitivity and specificity of the gene, the probe and the primer, real-time corresponding and quantitative analysis, high accuracy, simple operation and small required sample amount; the P59<fyn> gene expression level peak value which is detected by a real-time corresponding quantitative analysis method is consistent with CD4+, CD8+ lymphocyte infiltration time in a transplantation heart myocardium organization.
Description
Technical field:
The present invention relates to a kind of rat lymphocyte P59
FynGene quantification is expressed test primer, probe
Technical background:
At present, organ transplantation is still the effective ways of many organs of treatment and tissue pathology in whole latter stage.But immunological rejection also remains one of main reason that causes organ transplantation treatment failure at present.Because making, the restriction of donor source can not realize that the optimization of donor and acceptor joins type, therefore allogenic antigen remains the immediate cause that causes rejection, and this also makes the success of clinical organ transplantation more depend on the early discovery of immunological rejection and control in time.
P59
FynBe one of phosphate tyrosine kinase (PTKs) family member, mainly in the T cell, express, and be connected in the endochylema afterbody of CD4 and CD8.It is the important component in the T cell activation signal transduction pathway.When identification took place antigen peptide-MHC mixture of at surface of cell membrane antigen presenting cell APC being presented as TXi Baoshouti TCR and CD4 or CD8, CD4 or CD8 afterbody bonded comprised P59
FynBe caused to less and the endochylema caudal action of the cellular immunization molecule CD3 in the TCR complex proteins at interior Tyrosylprotein kinase, tyrosine phosphatase binding site generation phosphorylation in its relevant tyrosine structural domain of catalysis, immune signal is transmitted in the T cell, and mediation activates the genetic transcription and the expression of a series of cellular immunization molecules, activating T cell.So tyrosine protein kinase P59
FynGenetic expression be the early stage representative indication of T cell activation.
The measuring method of existing immune molecule genetic expression comprises: gene difference display gray scale scan method, in situ hybridization (sorthen blot) technology etc., but aforesaid method is complicated, accuracy and poor repeatability and problem such as isotopic contamination is arranged, and therefore is necessary to provide a kind of primer and probe that quick accurate quantification is measured the immune molecule gene expression dose that adapt to.
Summary of the invention:
The purpose of this invention is to provide a kind of rat lymphocyte P59
FynGene quantification is expressed test with primer and probe, utilizes this primer and the probe can be to rat lymphocyte P59
FynGene is made real-time fluorescent PCR detection by quantitative, because this primer, probe has and testing gene homologous high specific and high affinity, can obtain the result of highly sensitive, high precision and repeatability.
For achieving the above object the present invention by the following technical solutions: primer provided by the invention and probe sequence are:
CDNA probe: 423-FT 5 ' TGCAGCACCCTTCCAGCGCAACC 3 '
Primer: 378U 5 ' TCGCGGTGAAGGCTATGT 3 '
485L 5’CCAGGTTCTCCCCCTCACTAA 3’
P59
FynGene total order and probe thereof, primer location See Attachment 1
Wherein: 378U is a upstream primer, is normal chain
423-FT is a probe, is anti-chain
485L is a downstream primer, is anti-chain
Description of drawings:
β-the actin and the P59 of the different samples that Fig. 1 real-time fluorescence quantitative PCR is measured
FynGene amplification curve (in the experiment point) sometime
Fig. 2 is that different time is transplanted CD4+, CD8+ lymphocytic infiltration curve and P59 in the cardiac muscular tissue before and after the cardiac allograft rejection in rats art
FynGene quantification is expressed curve ratio
Fig. 3 P59
FynThe comparison of amplification curve during different templates concentration
Fig. 4 P59
FynThe agarose electrophoresis figure of gene amplification product
P59 in Fig. 5 PCR reaction
FynThe Auele Specific Primer fundamental diagram
Fig. 6 P59
FynThe specific probe synoptic diagram
Embodiment
The invention will be further described by the following examples
Experiment rat lymphocyte P59 among the present invention
FynThe preparation method of gene-specific probe and primer: at first according to P59
FynThe gene total order is carried out rat lymphocyte P59 with the primer-design software bag
FynSpecific probe and primer design, and designed primer and probe screened, select best primer and probe combinations and experimentize.
Embodiment:
1, the experiment grouping
Selecting the wistar rat is acceptor, and the SD rat is a donor, body weight 200-220g, male and female half and half (purchasing the animal center in Military Medical Science Institute--secondary animal).Be divided into 6 time groups, that is: 24h, 72h, 7d, 10d, 12d organize every group of 6 rats after the preceding group of transplanting, the heart transplantation.
2, blood specimen collection
Each organizes the wistar rat respectively at corresponding time point before and after transplanting, through 3% vetanarcol intraperitoneal anesthesia, and abdominal aortic blood 4ml, 2%EDTA anti-freezing in 1: 9.Be used to extract total RNA and quantitative PCR detection, get heart transplant simultaneously and do pathological section and carry out immunohistochemical methods and measure CD4+ and CD8+ lymphocytic infiltration number.
3, total RNA extracts
The lymphocyte separation medium isolated lymphocytes.Adopt the operation of Trizol method (GIBCO company test kit) by specification: lymphocyte is added 1ml Trizol make lysis, 4 ℃ of centrifugal 12000rpm 10 minutes, get supernatant, add 0.2ml chloroform concussion mixing, 4 ℃ of centrifugal 12000rpm 20 minutes, get the superiors and add the 0.5ml Virahol, 4 ℃ of 12000rpm are centrifugal 15 minutes, abandon supernatant and stay precipitation, add 1ml 75% ethanol, jog dissolving RNA, 7500rpm4 ℃ is centrifugal 5 minutes, abandon supernatant, after the ethanol volatilization total RNA is dissolved in the 50 μ l 0.1%DEPC water.
4, reverse transcription PCR (RT-PCR) and quantitative PCR
Reaction system is 24ul, comprising: total RNA 2ul (5ug/ml), Mg
2SO
41ul (25uM), dNTP 1ul (10mM), RT-PCR enzyme mixture 1ul, buffer 5ul, β-actin or P59
FynEach 2ul of gene upstream and downstream Auele Specific Primer (31.25uM), β-actin or P59
FynGene-specific probe 2ul (3.13uM), all the other are supplied with 0.1%DEPC water, reaction conditions be 42 ℃ 30 minutes, 95 ℃ of sex change 15 minutes, 1 circulation; 94 ℃ of sex change 30 seconds, 58 ℃ of annealing 60 seconds, 72 ℃ were extended 5 circulations 60 seconds; 94 ℃ of sex change 10 seconds, 60 ℃ were extended totally 40 circulations 60 seconds; Be cooled to 40 ℃ at last.
P of Rats 59
FynThe basic functional principle of gene-specific primer and probe:
P59 in the PCR reaction
FynAuele Specific Primer principle of work (see figure 5).
P59
FynOpen chain P59 during the annealing temperature of gene-specific primer in PCR reaction and behind the reverse transcription
FynThe complete complementary combination in specific region of cDNA nucleotide chain, and when elongating temperature, guide corresponding P59
FynNucleotide chain duplicate amplification.Process as shown.Its characteristics: because the specificity of primer is only carried out P59 when having realized the PCR reaction
FynDuplicating and increasing of gene cDNA do not have the amplification of non-specific gene.
P59
FynThe specific probe (see figure 6) of gene.
The designed probe of this experiment is the Taqman probe, and probe 5 ' connects a Fam fluorophor (this fluorophor all can detect) in the 520-740um wavelength region, and 3 ' end connects 1 Tamra quenching group, and this two group is the automatic mark of dna synthesizer.The P59 that PCR when reaction specific probe at first generates with reverse transcription last time
FynCDNA specific region nucleotide sequence is realized complete complementary combination, but because this moment, the fluorescence report group is controlled by quenching group and is not fluoresced, when cyclic amplification next time, the Taq enzyme combines when extending to specific probe and template bonded position with template under specific primer-primed, Taq enzyme wherein cuts off specific probe in the time of 60 ℃, the fluorescence report group separates with quenching group, cause fluorophor luminous, the quantitative PCR instrument writes down fluorescence intensity simultaneously, the template number of cDNA before being used for quantitatively this time increasing.
Adopted the relative quantitative assay method as the initial copy number of object of reference among the present invention with β-actin.
Because the expression level of lymphocyte β-actin mRNA is only relevant with cell count, and its content constant in cell, this experiment with β-actin as object of reference.Utilize β-actin and the P59 of real-time fluorescence quantitative PCR technology to same sample template
FynGene expression dose is measured simultaneously.If each gene is in 40 amplification cycles, the cycle number that fluorescence intensity begins to increase from baseline is Ct.Be the initial cycles number of Ct value representation gene when beginning to increase, (reflection template radix).Because 10 times of the every increases of the template radix of cDNA, the cycle number that begins to increase (Ct value) just reduces 3.33, so the difference of different sample template radixes can be by formula:
10
(CtA-CtB)/3.33Calculate.P59
FynMultiple with respect to β-actin template number is:
10
(P59fyn-β-actin)/3.33。
Among Fig. 1, following arrow is β-actin, and upward arrow is P59
Fyn
Wherein: with the test result of putting four routine samples before the cardiac allograft rejection in rats art sometime is example,
See Table 1
Table 1
Numbering | P59 fyn | β-actin | 10(p59-β-actin) /3.33 |
1 2 3 4 | 12.44 12.83 12.31 13.95 | 7.692 7.803 8.027 7.863 | 26.658 32.330 19.328 67.286 |
Average | 36.40±21.267 |
In the above-mentioned table, the P59 that average 36.40 ± 21.267 expressions four routine sample quantitative PCRs (starting template multiple relatively) are measured
FynThe Ct value is to the average+standard deviation of the relative multiple of β-actinCt value,
Two kinds of comparative results see Table 2 and Fig. 2
Shi Yan immunofluorescence tissue staining as a comparison:
Get the original position heart of SD rat before transplanting respectively and transplant the transplantation donor heart of each time group of back, freezing back in 1/3 place crosspiece face section far away, 95% ethanol is 30min fixedly, PBS washing 3 times, each 5min, use fluorescently-labeled anti-CD4, CD8 labeling of monoclonal antibodies respectively, 37 ℃ of constant temperature are hatched 30min, PBS washing 3 times, each 5min, 4 ℃ keep in Dark Place after the glycerine mounting, carry out CD4 under the fluorescent microscope respectively
+, CD8
+The lymphocyte numeration.
The (see figure 1) real-time fluorescence quantitative PCR is measured peripheral blood lymphocyte P59
FynGene expression dose (P59
FynMultiple to β-actin) measure to transplant CD4+ in the cardiac muscular tissue, CD8+ lymphocyte (number) with the immunohistochemical methods method and soak into number compare (see Table 2 and Fig. 2)
Table 2 CD4, the infiltration of CD8 rat implantation control group, molecule and P59
FynGenetic expression relatively
Before the art | | | 7d | 10d | 12d | |||
CD4+ soaks into CD8+ and soaks into P59 fynGene | 15.5 16.8 36.4 | 4.8 3.3 87.7 | 5.3 3.7 95.3 | 11.8 8.2 77.6 | 9.2 6.5 98 | 11.8 6.7 44.3 |
P59 in the table
FynIts numeral of genetic expression is peripheral blood lymphocyte P59
FynThe template multiple of gene pairs β-actin encoding gene, numeral increase the negative mileometer adjustment of expression and reach.
Among Fig. 2,3 curves are arranged, 1 is CD4+ lymphocytic infiltration curve, and the time that the infiltration peak value appears in the A point expression on the curve is 7 days; 2 is CD8+ lymphocytic infiltration curve, and the time that the infiltration peak value appears in the B point expression on the curve is 7 days; Be P59
FynGene quantification is expressed curve, and the time that positive mileometer adjustment peaking appears in the C point expression on the curve is postoperative 7 days.Article three, the variation tendency unanimity of curve.
As seen from Figure 2, with different time before and after the cardiac allograft rejection in rats art, myocardium CD4+, CD8+ lymphocytic infiltration change and peripheral blood lymphocyte P59
FynChanges in gene expression relatively be example: in post-transplantation in the time of the 7th day, transplant that CD4+, CD8+ lymphocytic infiltration reach the postoperative peak value, peripheral blood lymphocyte P59 in the cardiac muscle
FynAlso in rise in the time of the 7th day first peak value after reaching transplanting of postoperative, the result shows peripheral blood lymphocyte P59 to the gene relative expression quantity
FynGene quantification express at least with transplant cardiac muscle in CD4+, CD8+ lymphocytic infiltration to reach time of postoperative peak value consistent.
Can see specificity of the present invention and susceptibility from Fig. 3, Fig. 4.1 expression template concentrations is 3.288ug/ml among Fig. 3, and 2 expression template concentrations are 3.288 * 10
-1Ug/ml, 3 expression template concentrations are 3.288 * 10
-2Ug/ml, 4 expression template concentrations are 3.288 * 10
-3Ug/ml, 5 expression template concentrations are 3.288 * 10
-4Ug/ml is in Fig. 3, when template concentrations is diluted to 3.288 * 10
-4Also can obtain good Ct value and amplification curve during ug/ml.Among Fig. 4, agarose electrophoresis result is that this primer has single amplified band, wherein five samples of 1,2,3,4,5 expressions.
The sensitivity of advantage of the present invention: Ben Jiyin, probe and primer and specificity are good, real-time relative quantitative assay, and the accuracy height, simple to operate, required sample size is little, does not have wound, adopts real-time relative quantitative assay method to detect peripheral blood P59
FynGene expression dose posttransplantation first peak value with transplant cardiac muscle in CD4+, CD8+ lymphocytic infiltration number to reach time of postoperative peak value consistent.
Annex one
1 atgacagcca aggagatgaa ggcgaccgag agtgcggcgc agccggtgcc gctgcccaag
61 aaggaagtgg atgtcagccc caaacaggat gaaggagtgc tgaaagtcat caagacagag
121 ggcacaggta cagagatgcc catgactggg gacctagtct ttgtccacta cactggctgg
181 ctgttagagg gcacaaagtt tgactccagt gtggatcgca aggacaaatt ctcctttgac
241 ctgggaaaag gggaggtcat caaggcttgg gacattgccg tagcaaccat gaagttcagc
301 agacagtcct ccaacgatct ccccataacg ccacgcttgt gtttgaaaga tgggggaatc
361 atccgcagaa tagggact
cg cggtgaaggc tatgtcaagc ccgatgaggg cgctatggtg
378U
421 gag
gttgcgc tggaagggtg ctgcaaggac cagctctttg accaacgggc gctccgcttt
423-FT
481 gaggt
tagtg agggggagaa cctggatctg ccttatgatc tcgagagggc cattcagcac
485L
541 ttggagaaag gagaacattc cactgtgtac ctcaagccca gctatgcttt tggcagtgtt
601 gggaaggaaa agttccaaat cccaccaaat gccgagctga aatatgaatt atatctcaag
661 agttttgaaa aggccaagga atcttgggag atgatttcag aagagaagct ggaacagaac
721 accgtagtga aagagcaggg cagtgtgtac ttcaaggaag gcaaatacaa gcaagcttta
781 ctacagtcac agaaggcaca ggcccctcca ctggcctctc acctcgacct ggccatgtgt
841 cagctgaaac tacaggcctt ctctgctgcc attgaaagct gtaacaaggc cctagaactg
901 gacagcaaca acgagaaggg ccccttccgc cggggagagg cccacctggc ggtgaatgac
961 tttgaactgg catgggctga cttccagaag gtcctgcagc tctaccccaa caacaaagcc
1021 gccagggccc agctggctgt gtgtcagcag cggatccaca ggcagcttgc ccggaagaag
1081 ttctatgcca aaatgtttga gaggctggct gaggaggaga acaaggccaa ggcagaggct
1141 tgctcaggag accatcccac tgacacagag atgaaggcgg agtggaagag caacacagca
1201 gggagccagt ctcaggtgga gacagaagca tag
Sequence table
<110〉Beijing Institute of Cardiopulmonary Vascular Disease
<120〉rat lymphocyte P59fyn gene quantification is expressed test primer, probe
<130>
<160>3
<170>PatentIn version 3.1
<210>1<211>23<212>DNA
<213〉synthetic
<400>1
tgcagcaccc ttccagcgca acc 23
<210>2
<211>18
<212>DNA
<213〉synthetic
<400>2
tcgcggtgaa ggctatgt 18
<210>3
<211>21
<212>DNA
<213〉synthetic
<400>3
ccaggttctc cccctcacta a 21
Claims (1)
1, a kind of rat lymphocyte P59
FynGene quantification is expressed test and is used primer, and it is characterized in that: in the described primer sequence, the sequence of upstream primer 378U is 5 ' TCGCGGTGAAGGCTATGT 3 ', and the sequence of downstream primer 485L is 5 ' CCAGGTTCTCCCCCTCACTAA 3 '.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021461333A CN100344770C (en) | 2002-11-01 | 2002-11-01 | Primer, probe for rat lymph cell P59 fyn gene quantitative expression test |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021461333A CN100344770C (en) | 2002-11-01 | 2002-11-01 | Primer, probe for rat lymph cell P59 fyn gene quantitative expression test |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1493700A CN1493700A (en) | 2004-05-05 |
CN100344770C true CN100344770C (en) | 2007-10-24 |
Family
ID=34232643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021461333A Expired - Fee Related CN100344770C (en) | 2002-11-01 | 2002-11-01 | Primer, probe for rat lymph cell P59 fyn gene quantitative expression test |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100344770C (en) |
-
2002
- 2002-11-01 CN CNB021461333A patent/CN100344770C/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
肾移植术后外周血淋巴细胞P59fyn和SLAM基因表达的动态观察 心肺血管病杂志,第20卷第4期 2001 * |
Also Published As
Publication number | Publication date |
---|---|
CN1493700A (en) | 2004-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1688708A (en) | Gene sequence method for testing T cell propagation | |
CN1526022A (en) | Testing endosymbiont cellular organelles and compounds identifiable therewith | |
CN101608240A (en) | Be used to detect primer, probe and the using method thereof of human EGFR gene sudden change | |
CN1873027A (en) | Primer in use for in vitro diagnosing GJB2 mutation of deaf gene of autosomal recessive inheritance in non-syndrome | |
CN101058830A (en) | Pig pestivirus fluorescence quantitative RT-PCR diagnosis agent kit | |
CN1245522C (en) | Testing method for matrilinear hereditary deaf mitochondria gene 1555 place A-G catastrophe and reagent boxes | |
Sun et al. | Development and evaluation of a sensitive and quantitative assay for hirame rhabdovirus based on quantitative RT-PCR | |
CN1506468A (en) | PCR test kit for hygrophilous aeromonad and its test method | |
CN100344770C (en) | Primer, probe for rat lymph cell P59 fyn gene quantitative expression test | |
CN101045939A (en) | HBV DNA gene subtype detecting method and kit | |
CN1824801A (en) | Real-time fluorescent PCR testing primer, probe and immobilized kit for citrus ulcer bacteria and testing process thereof | |
CN1712547A (en) | Fluorescent quantitative RT-PCR detecting kit of 2-f(o)etoprotein (AFP)mRNA | |
CN1282750C (en) | FQ-PCR diagnosis kit of WSSV and test method | |
CN1188531C (en) | Prawn white spot complex virogene diagnostic kit and detecting method thereof | |
CN1932038A (en) | Method of detecting JAK2V617F mutation and its special primer and TaqMan MGB probe | |
CN107385089B (en) | Nucleic acid combination, kit and method for detecting cryptosporidium oocysts | |
CN101051026A (en) | Double real time fluorescence PCR detecting method for vancomycin enterococcus | |
CN110791570A (en) | Primer group and kit for simultaneously detecting Wei-type, Si-type and heterodiscal paragonimiasis | |
CN1180092C (en) | Rockfish viral nerve necrosis virogene diagnostic kit and detecting method thereof | |
CN1847408A (en) | Thrombocyte glucoprotein HPA-1 and HPA-2 genotype detecting chip and its use | |
CN1188530C (en) | Gene detection reagent kit for SARS virus and its detection method | |
KR101754076B1 (en) | Method and kit for genotyping HLA-DRB1 and HLA-DRB3/4/5 using real-time PCR | |
CN1858255A (en) | Two step method multiple RT-PCR solidified detection reagent kit for potato virus disease and its detecting method | |
CN1904067A (en) | B type grippal virus fluorescent augmentation detection kit and detection method | |
JP5316749B2 (en) | Cisplatin resistance gene diagnosis method and cisplatin therapeutic effect gene diagnosis kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |